Appeals Court Deals Blow To Pfizer
In a stinging setback for Pfizer Inc., a federal appeals court on Thursday invalidated three claims of a patent covering the company's second-biggest drug and reversed a lower court's decision that...To view the full article, register now.
Already a subscriber? Click here to view full article